These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3216037)

  • 1. The absorption and disposition of enoxacin in healthy subjects.
    Somogyi AA; Bochner F
    J Clin Pharmacol; 1988 Aug; 28(8):707-13. PubMed ID: 3216037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.
    Misiak PM; Eldon MA; Toothaker RD; Sedman AJ
    J Clin Pharmacol; 1993 Jan; 33(1):53-6. PubMed ID: 8429114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of enoxacin and its oxometabolite following intravenous administration to patients with different degrees of renal impairment.
    Van der Auwera P; Stolear JC; George B; Dudley MN
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1491-7. PubMed ID: 2221856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enoxacin--comparative pharmacokinetics and tissue penetration].
    Sörgel F; Naber KG; Metz R; Morgenroth A
    Infection; 1989; 17 Suppl 1():S14-8. PubMed ID: 2680989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral antacids on disposition of intravenous enoxacin.
    Nix DE; Lebsack ME; Chapelsky M; Sedman AJ; Busch J; Norman A
    Antimicrob Agents Chemother; 1993 Apr; 37(4):775-7. PubMed ID: 8494374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible mechanism of interaction between xanthines and quinolone.
    Hasegawa T; Nadai M; Kuzuya T; Muraoka I; Apichartpichean R; Takagi K; Miyamoto K
    J Pharm Pharmacol; 1990 Nov; 42(11):767-72. PubMed ID: 1982300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxacin absorption and elimination characteristics.
    Toothaker RD
    Clin Pharmacokinet; 1989; 16 Suppl 1():52-8. PubMed ID: 2653697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of enoxacin in renal disease.
    Bury RW; Becker GJ; Kincaid-Smith PS; Moulds RF; Whitworth JA
    Clin Pharmacol Ther; 1987 Apr; 41(4):434-8. PubMed ID: 3470166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic characteristics of N7-substituted theophylline derivatives and their interaction with quinolone in rats.
    Hasegawa T; Nadai M; Apichartpichean R; Muraoka I; Nabeshima T; Takagi K
    J Pharm Sci; 1991 Oct; 80(10):962-5. PubMed ID: 1664467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment.
    Novelli A; Reali EF; Amato M; Dami A; Fallani S; Periti P
    J Chemother; 1989 Jul; 1(4 Suppl):546-8. PubMed ID: 16312526
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of gastric acidity on enoxacin absorption.
    Lebsack ME; Nix D; Ryerson B; Toothaker RD; Welage L; Norman AM; Schentag JJ; Sedman AJ
    Clin Pharmacol Ther; 1992 Sep; 52(3):252-6. PubMed ID: 1526081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of milk and food on the absorption of enoxacin.
    Lehto P; Kivistö KT
    Br J Clin Pharmacol; 1995 Feb; 39(2):194-6. PubMed ID: 7742162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics.
    Sörgel F; Mahr G; Granneman GR; Stephan U; Nickel P; Muth P
    Clin Pharmacokinet; 1992; 22 Suppl 1():65-74. PubMed ID: 1319873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.
    Marchbanks CR; Mikolich DJ; Mayer KH; Zinner SH; Dudley MN
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1966-72. PubMed ID: 2291662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.